Insights

What is Your Data Integration and Analytics Platform Strategy?

If I Could Only Ask Two Questions, the First One Would Be: What is Your Data Integration and Analytics Platform Strategy? It’s really simple, data analytics drives decisions. In the healthcare industry, we use data to…

A Patient Hero

Articles

PharmaVOICE Precision Medicine Showcase

Improving Patient Adherence With Behavioral Health Technology The industry’s shift to outcomes-based, patient-centered care requires new approaches to patient support to achieve adherence and therapeutic success. Today’s patients are also highly motivated information seekers and are…

PharmaVOICE Connected Health Showcase

IF I COULD ONLY ASK TWO QUESTIONS, THE FIRST WOULD BE: What is your data integration and analytics platform strategy? As the industry continues its shift to a patient-centric, value-based model of care, it is critical…

Proactive Steps to Ensure Appropriate Utilization of the First Disease-Modifying Therapy for Alzheimer Disease

Widespread hope exists that aducanumab will soon gain Food and Drug Administration approval as the first disease-modifying therapy for patients with mild cognitive impairment associated with Alzheimer disease (AD), which could significantly impact the management of…

Two Key Questions About Payer Strategies in 2020

In a PM360 Focus on Payer Strategies feature, Brian Davis addresses the question: Besides efforts to lower drug prices and increase transparency, what market access challenges/barriers will cause pharma companies the most stress this year? How…

PharmaVOICE Showcase on Connected Health and IoT

The Growing Potential of Connected IoT In PharmaVOICE’s Showcase on Connected Health and IoT, Ed Cox offers executive viewpoints on the challenges of integrating the Internet of Medical Things (IoMT) into pharma processes. “Breaking down siloes…

How COVID-19 Has Changed Payer Engagement Strategies

The healthcare industry is rightly focused on COVID-19 and its impact on patient care and allocation or utilization of healthcare resources. However, we cannot lose sight of our responsibility to provide appropriate therapeutic options for the…

PharmaVOICE Rare Disease Showcase

Why should pharmaceutical manufacturers in the rare disease space channel and communicate their inner WHY to patients? Because it’s how we can improve the adherence rate of orphan drugs from a low 60%, which the industry…

COVID-19 Payer Pulse Research Summary

The current public health pandemic is impacting healthcare stakeholders from doctors and nurses in the frontline to payers and PBMs. EVERSANA is monitoring the constant changes to access and benefit consideration tracking payer responses and key…

ACCESSEXPRESS® by EVERSANA Payer Coverage and Reimbursement Case Study

ACCESSEXPRESS allows you to have full control of the survey process getting answers to your most pressing business questions within hours. See how our client used our research platform to assess payer coverage and reimbursement for…

Oncology Market: Outlook of Brand Access and Insights

The oncology market is constantly changing and EVERSANA continues to assess current and future market trends, payer willingness to pay and the optimal patient support services to ensure you have all the insights you need to…